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ABSTRACT
Heart abnormalities in cirrhotic patients have been known for five decades, with atria and ventricular
dilatation. Pozzi et al reported that in cirrhotic patients with or without ascites, the diastolic function was
lower than control. Ascitic paracentesis improved diastolic function. The diameter of both atria was larger in
cirrhotic patients with or without ascites. The diastolic diameter of left ventricle did not differ significantly in
cirrhotic patients with or without ascites compared to control, but there was an increase after paracentesis.
Ejection fraction was lower in cirrhotic and increased after ascitic parancentesis although the increase was
not significant. The aim of the Study: To compare the function and structure of the heart before and after
ascitic paracentesis in cirrhotic patients.
Methods: This study took place from February 2000 to April 2001 in dr. Pringadi Hospital/H.Adam Malik
Hospital. There were 18 samples (12 men and 6 women), 15 of which were cirrhotic patients with tense
ascites and 3 cirrhotic patients with refractory ascites. The mean age was 51,8 + 8,28 years, the youngest
being 29 years and the oldest 65 years. The mean ascitic fluid removed by paracentesis was 7,20 liters with
a range of 5 to 9 liters. Immediately following paracentesis, Dextran 40 % was administered at a dose of 8g/
1L ascitic fluid aspirated.
Results: The diameter of the four heart chambers decreased after paracentesis, but the decrease was not
statistically significant. There was increase in E/A ratio after ascitic paracentesis, from 0,93 + 0,370 to 1,06
+  0,383 (significant, p<0,05), meaning that there was an improvement in diastolic function after ascitic
paracentesis. There was also an increase in ejection fraction from 68,99 + 13,26 %  to 72,10 + 11,10 %, but
this was not significant (p>0,05).
Conclusion: After paracentesis, there was a significant improvement in diastolic function while the
diameter of the four heart chambers decreased and the ejection fraction increased insignificantly.
Keywords: Ascitic paracentesis - liver cirrhosis - heart function and structure.
INTRODUCTION
Ascites is a symptom indicating the severity of liver
cirrhosis. The prognosis of cirrhosis following the
appearance of ascites ranges from 1-2 years.  The
prevalence of ascites in liver cirrhosis ranges from 10-
89%, with annual incidence rates ranging from 3-10%.1
Heart disorders in liver cirrhosis patients have been known
since over 50 years, but the more specific possibilities
have been detected just recently.2 The disorders found
are marked with electrophysiological and mechanical
disruptions, mainly as a response to stress loads.3
Cirrhotic patients undergoing maximum treadmill test
have only a 97% increase in cardiac output, compared
to control subjects who have an up to 300% increase in
cardiac outputs under the same load.4  This situation is
accompanied with an increase in thickness and rigidity
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of ventricle walls that leads to disruptions of diastolic
function with a variety of fractions.3,5 Atrial and
ventricle diameters are greater in liver cirrhosis patients
with ascites.6,7,8 The diameter of the left atrium, which
is greater than in control subjects, demonstrates the
presence of fluid retention, and disorder in left ventricle
contraction.  The increase in systolic and diastolic
ventricle diameter in liver cirrhosis is interpreted as a
secondary impact to the increase in circulating blood
volume.  Pozzi et al reported that the ejection fraction of
the left ventricle is lower in liver cirrhosis patients with
ascites compared to normal people, and will increase
following paracentesis even though the increase was not
significant.9 His study in liver cirrhosis patients with
ascites also demonstrate increased ventricle diameter
24 hours following total paracentesis, whereas the atrial
diameter was not changed compared to pre-
paracentesis.6,8
In liver cirrhosis with or without ascites, failure in
diastolic function is found, marked by decreased E/A
ratio compared to normal subjects. There is improved A
wave and E/A ratio following paracentesis. Ejection
fraction is an evaluation of the left ventricle systolic
function. It can be measured by measuring the end
diastolic volume and end systolic volume. The E wave
rapid filling phase of the left ventricle is followed by an
opening of the distal valve.  The A wave left ventricle
filling is followed by normal atrial contraction E/A ratio
of >1.10
Based on the information above, the author studied
the relationship between  ascites in liver cirrhosis and
the changes of heart function and structure.
Diastolic function consists of 4 phases:
1. Iso-volume relaxation time
2. Rapid filling phase (E wave)
3. Diastalsis (equal pressure of left ventricle and right
ventricle)
4. Atrial contraction phase (A wave)
THE AIM OF STUDY
To compare the function and structure of the heart prior
to and following ascites paracentesis in liver cirrhosis.
MATERIALS AND METHODS
This study is experimental, conducted from February
2000 to April 2001 at Dr.Pirngadi Hospital/ Adam Malik
Hospital, Medan.
Case group: Patients with liver cirrhosis with
ascites who were not responsive to high-dose diuretics
therapy (400 mg spinorolakton and 40 mg Furosemide).
The  patients were diagnosed based on Suharyono
Subandiri criterias and USG.
Exclusion:  heart diseases (valve disorder,
hypertension, congenital heart disease, cardiomyopathi,
cardiac arrhythmia), severe lung disease, systemic
disease, bleeding in less than 3 months, anemia of Hb<7
gr/dl, liver cancer, hepatic encephalopathy, creatinine
levels of more than 1.5 mg%, alcohol consumption in
less than 3 months, those undergoing treatment for
hypertension, bilirubine levels of more than 10 mg%,
platelet counts of less than 40.000/mm3.
Patients underwent routine laboratory check up, liver
function test, SPE and renal function test.  Then
echocardiography was taken as a preliminary data.
Ascites liquid paracentesis was conducted to the
minimum with abocathe number 16 under ultrasound
guidance. After parasentesis was performed, the patient
received infusion with Dextran 40% 8 gr/l ascites fluid.
Repeat echocardiography was performed 24 hours
following paracentesis.
The parameters measured:
• Left and right atrial diameters
• Left and right ventricle diameters
• Left ventricle ejection fraction
• E/A ratio
Echocardiography was performed with Logic 500
made by General Electric USA, using   the American
Society of echocardiography criteria.11
RESULTS
Out of 18 patients with liver cirrhosis with ascites
(12 males and 6 females), 15 patients had tense ascites
and 3 patients were not responsive to high dose diuretics
therapy (400 mg Spironolactone and 40 mg Furosemide).
The mean age was 51.8 + 8.28 years. The youngest
was 29 years old and the oldest was 65 years old.
Table 1 A Comparison of Blood Pressures Prior to and  
Following Paracentesis 
Variable n X (mmHg) SD p 
S-BP-1 18 119.17 8.09 0.079 S-BP-2 18 115.28 7.57 
D-BP-1 18 74.5 5.11 0.049 D-BP-2 18 72.50 4.93 
Note 
S-BP : Systolic blood pressure 
D-BP : Diastolic blood pressure 
1 : Prior to paracentesis 
2 : Following paracentesis 
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From the table above, it can be seen that following
paracentesis, there was a decrease in both systolic and
diastolic blood pressures.  Yet, the decrease was not
statistically significant (p>0.05).
From table above, it is demonstrated that there was
no difference in the velocity of the E wave, prior to and
following paracentesis (p>0.05).
From the table above, it can be seen that in all four
chambers of the heart, there was a decrease in
diameter following paracentesis.  Yet, the decrease was
not statistically signicant (p>0.05).
From the table above, it was revealed that there was
an increase in the E/A ratio from 0.93 + 0.370 to 1.06 +
0.383.  This increasing was statistically significant
(p<0.05).  In other words, there was an improvement in
diastolic function following ascites paracentesis.
From table above, it is shown that there was a
significant decrease in A wave following paracentesis
from 0.690 + 0.157 m/s to 0.621 + 0.122 m/s (p>0.05).
From table above, it is shown that there was an
increase in ejection fraction from (68.99 + 13.26)% prior
to paracentesis to (72.10 + 11.10)%.  However, the
increase was not statistically significant (p>0.05).
DISCUSSION
In portal hypertension, peripheral vasodilatation and
sodium retention are hemodynamic disorders preceding
plasma volume expansion leading to a hyperdynamic
situation in liver cirrhosis.  The pathogenesis of this
hyperdynamic situation in liver cirrhosis is the increase
in vasodilator substances that are normally metabolized
by the liver.12 These substances are: intestinal
polypeptide vasoactive, prostacyclin, endotoxin,
glucagons, and endothelial relaxation factor, nitric oxide
and alpha TNF.13,14  Another mechanism is the failure
of the liver to produce vasoconstrictor substances. There
is also proof that the several vasodilators produced and
some substances that are inactivated or secreted by the
lungs are inable to pass through the lungs due to arterial
venous shunting.
The study by Kowalski et al in the year 1950
demonstrated a hyperdynamic circulation in liver
cirrhosis manifested in increased cardiac output and
decreased systemic vascular resistance and the
Table 2. A Comparison of the Diameter of the Four 
Heart Chambers Prior to and Following Paracentesis 
Variable n X 
(mmHg) 
SD p 
D-RA-1 18 26.87 5.73 0.591 D-RA-2 18 26.31 6.67 
D-LA-1 18 32.78 3.72 0.155 D-LA-2 18 31.40 3.90 
D-RV-1 18 33.57 6.67 0.637 D-RV-2 18 33.20 6.81 
D-LV-1 18 49.81 7.38 0.154 D-LV-2 18 48.37 6.84 
Note: 
D-RA : Diameter of the right atrium 
D-LA : Diameter of the left atrium 
D-RV : Diameter of the right ventricle 
D-RV : Diameter of the left ventricle 
Table 3. A Comparison of the A/A Ratio Prior to and  
Following Paracentesis 
Variable n X 
(mmHg) 
SD p 
E/A-1 18 0.93 0.370 0.002 E/A-2 18 1.06 0.383 
 
Tabel 4. A Comparison of E-wave Prior to and Following  
Paracentesis 
Variable n X 
(mmHg) 
SD Df t-test p 
E-WAVE-1 18 0.626 0.185 17 0.48 0.640 E-WAVE-2 18 0.636 0.191  
Note: 
E-wave on echocardiography 
Table 5. A Comparison of A-wave Prior to and Following 
Paracentesis 
Variable n X 
(mmHg)  
SD p 
A-W AVE-1 18 0.6 90 0.157 0.001 A-W AVE-2 18 0.6 21 0.122 
Note : 
A-WAVE: A-wave on echocardiograp hy 
 
Table 6. A Comparison of Ejection Fraction Left  
Ventricle Prior to and Following Paracentesis 
Variable n X 
(mmHg) 
SD p 
EF-1 18 68.99 13.26 0.214 EF-2 18 72.10 11.10 
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presence of peripheral vasodilatation.9,11 Several
studies also show that in portal hypertension with or
without primary liver disease, there is limited heart
function. The limitations include minimum preload
reservation and failure of heart contraction.  Elements
correlating with vasodilatation cause disorders of the two.
The chronic increase in cardiac output and humoral
factors such as alpha TNF could disrupt cardiac
function.14 In liver cirrhosis, hepatocellular failure is
obviously found. This failure may result in the
accumulation of toxins, such as endotoxins, which are
normally cleaned or inactivated by the liver. Such toxic
substances have a direct effect on the heart. In the liver
cirrhosis, there is also an increase in norepinephrine,
which is known to be able to cause the myocardial
damage and desensitized beta adrenergic receptors.14
Ventricular failure in liver cirrhosis often appears due
to medical intervention such as liver transplantation,
portosistemic shunt operation and Transjugular
intrahepatic portosystemic operation.  These procedures
induce physical stress to the heart, and installing a shunt
will lead to high venous return.  In a study, 7.3% of deaths
following heart transplantation was caused by congestive
heart failure.  Several heart failures have been reported
following the insertion of Transjugular  intrahepatic
portosistemik stent shunts, as quoted from. 9
Atrial and ventricular diameters are greater in liver
cirrhosis patients with ascites.  The diameter of the left
atrium, which is greater than in control subjects, show
fluid retention and abnormal contraction of the left
ventricle.11 The increase in systolic and diastolic
diameters of the ventricles in liver cirrhosis are
interpreted as a secondary impact to the increase in
circulating blood volume.9  Pozzi et al reported from a
study on liver cirrhosis patients with ascites that there
was an increase in ventricle diameter 24 hours following
total paracentesis, whereas the atrial diameter was not
changed as compared to pre-paracentesis.17 On the other
hand, Arbol et al reported that on the first day of
paracentesis cardiac index tended to increase, but it
returned to the figure prior to paracentesis following the
sixth day.15
In this study, both atrial and ventricle diameters
decreased following paracentesis even though the
decrease was not statistically significant (p>0.05).  The
results we obtained differed from the study by Pozzy et
al.  It may be due to differences in the method of study.
Pozzy used albumin to replace plasma fluid, while our
study used Dextran-40.  The use of Dextran-40 as plasma
replacement produced nearly 40-50% circulation failure,
marked by an over 50% increase of plasma renin
activity compared to the level prior to paracentesis, while
the use of albumin as plasma replacement produced only
15% circulation failure.15 In this study, plasma renin
activity was not examined.
The study by Pozzi et al reported a lower left
ventricle ejection fraction in liver cirrhosis patients with
ascites compared to non-ascites cirrhotic patients and
healthy subjects, even though still within the normal
range, and a slight increase following paracentesis.9
In this study there was an increase in the ejection
fraction following paracentesis from 68.99 + 13.26% to
72.10 + 11.10%, but it was not statistically significant
(p>0.05).
Doppler echocardiography was able to monitor
ventricular filling. The filling was divided into the
velocity of the peak wave filling during early ventricle
diastolis (E wave) and the velocity of wave filling during
atrial systolis (A wave).  The E/A wave velocity ratio is
usually used as an index for diastolic function.  Under
normal circumstances, the E wave is greater than the A
wave, while under abnormal conditions, it demonstrates
abnormal diastolic function where the role of the atrium
is more dominant than the early ventricle dilatation
component due diastolic rigidity of ventricle.6
In liver cirrhosis, there is an increase in the thickness
and rigidity of the ventricle wall, which leads to the
disruption in diastolic function.3  In a study, diastolic
function disorders were generally found in liver cirrhosis
with ascites, and there was also an increase in preload
caused by increased intravascular circulation volume and
decreased afterload caused by peripheral vasodilatation,
where both factors could prevent abnormal diastolic
function.  On the other hand, the physical effect of
ascites liquid liquid pushes the diaphragm into the
thoracic cavity, thus disturbing the function of the
ventricles.3,6
This study revealed a significant increase in E/A  ratio
from 0.93 + 0.370 to 1.06 + 0.383 (p<0.05).  From the
two components of wave that  determine the diastolic
function in this study, there was an increased A wave
and E wave, even though the increase in E wave was
not statistically significant (table IV-V).  In this study,
the difference in the diameter of the heart chambers
was not statistically significant prior to and following
paracentesis, thus, it may not be the dominant factor
leading to diastolic dysfunction.3,6
In conclusion the diameters of all four chambers of
the heart decreased following paracentesis but the
decrease was not statistically significant, the ejection
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fraction increased following paracentesis but the increase
was not statistically significant, there was a significant
improvement in diastolic function following ascites
paracentesis which is marked by the increase in E/A
ratio, there was a significant decrease in cardiac pulse
rate following ascites paracentesis.
Further study involving more samples and longer
follow up is required. Neurohumoral measurements are
needed to determine its role in changing the
hemodynamic status in this study.
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